Delta, Kelowna, BC – April 13, 2021 (Investorideas.com Newswire) www.Investorideas.com, a world information supply protecting main sectors together with marijuana and hemp shares and its potcast website, www.potcasts.ca launch at this time’s podcast version of hashish information and shares to observe plus perception from thought leaders and specialists.
Take heed to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/041321-StocksToWatch.mp3
Investor Concepts Potcasts #551 Hashish Information and Shares on the Transfer; (TSX-V: PKAN) (TSXV: EMH) (CSE: EASY) (CSE: IKNK.U) (TSXV: KHRN) (OTCQX: KHRNF)
SHARE PODCAST:
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
In the present day’s podcast overview/transcript:
Good afternoon and welcome to a different episode of Investorideas.com “Potcast” that includes hashish information, shares to observe in addition to insights from thought leaders and specialists.
In at this time’s podcast we have a look at just a few public firm bulletins.
PureK Holdings Corp. (TSX-V: PKAN), together with its majority-owned CBD subsidiary firm, PureKana LLC, (“PureKana”), announcedt hat it has entered right into a model partnership with main hashish and CBD retailer Chemesis Worldwide Inc. (CSE: CSI) (OTC: CADMF), underneath which PureKana’s industry-leading CBD merchandise will turn out to be out there at tons of of proprietary Chemesis kiosks all through america.
On account of this partnership, PureKana’s industry-leading vary of merchandise – together with its flavored pure hemp-derived CBD oils, sleep aids, immunity boosts, vegan CBD-infused gummies, soothing CBD-infused topical lotions, and CBD capsules – will turn out to be part of the everlasting product providing for Chemesis’ A.I.-powered VICKI Clever Self-Checkout platform.
Chemesis’ VICKI kiosks may be deployed in excessive visitors areas like buying malls, workplaces, and transit hubs and have proprietary applied sciences to reinforce the hashish retail expertise, together with age verification, loss prevention, product schooling, and A.I.-powered digital assistant applied sciences.
“Our partnership with Chemesis accelerates our omni-channel distribution of the PureKana Model. CBD schooling, innovation, and availability are foundational to our mission to allow wellness authentically on daily basis for our loyal customers,” stated Kathy Casey, CEO of PureK Holdings Corp.
“PureKana is a extremely regarded model by customers and inside the {industry} for his or her high quality and nicely branded merchandise,” stated President of Chemesis, Josh Rosenberg. “This partnership will enable Chemesis and PureKana to develop a cohesive technique to carry high-quality merchandise to customers by way of an alternate path to market. Working with a powerful model similar to PureKana, will give the VICKI platform one other edge over typical brick and mortar dispensaries.”
Emerald Well being Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) has launched its new product line, SYNC™ Tabs, an revolutionary, naturally-flavoured ingestible providing customers a managed 10 mg THC dose with predictable onset and offset. This product line expands its providing underneath its SYNC™ Wellness model and is the second of Emerald’s Outlined Dose™ merchandise. The primary provincial buy orders have been acquired and, starting April thirteenth, the tablets will likely be out there to customers at licensed hashish retailers and on-line in BC, Manitoba, and Newfoundland, with Alberta to comply with.
Emerald’s Hashish 2.0 and three.0 technique focuses on leveraging science-based innovation to serve focused shopper preferences. This differentiated new product line builds on Emerald’s dedication to providing customers outlined dosing and predictable actions that permit them management their hashish consumption expertise. SYNC™ Tabs are designed in a well-recognized pill type that allows handy but discreet hashish use.
With 10 mg of THC, SYNC™ Tabs provide customers the measured stringency of Emerald’s Outlined Dose™ normal, dissolve underneath the tongue in about three minutes, and supply desired results inside 20 to half-hour. Offset is equally managed, occurring inside roughly 90 minutes of taking the pill. This new product line follows the introduction of Emerald’s Nano Quick-Performing Spray product. Sublingual tablets add to the SYNC™ model’s line-up of non-smoking types of hashish merchandise, which additionally embrace CBD and THC hashish oils.
Designed to serve prospects’ use of hashish for day by day wellness routines, SYNC™ Tabs are sugar-free, gluten-free, vegan and are available in two pure flavours, cherry and mint. Produced with 100-percent coconut-derived MCT oil, the merchandise provide a sustainably-produced hashish wellness choice. Every pack incorporates 10 x 10 mg doses, providing 100 mg of THC in complete.
“Our product improvement efforts are centered on offering customers with distinctive hashish merchandise providing managed, predictable actions – with higher precision of dosing and the onset and offset of results,” stated Riaz Bandali, President and CEO. “We now have a proficient product improvement staff that’s enthusiastic about science and innovation. They’re transferring further new product strains towards launches deliberate for the following few months and quarters, which we anticipate to start out positively impacting our progress.”
SpeakEasy Hashish Membership Ltd. (CSE: EASY), a holder of a federal licence to domesticate, course of and promote hashish underneath the Hashish Act. announced that it has entered the ultimate stage of amending its gross sales license to permit the sale of its extracts and concentrates.
Founder, Marc Geen, “Extractions and concentrates are a quickly rising and an vital a part of the hashish market in Canada. We’re eagerly anticipating our licence that after granted, will enable us to take part on this thrilling section of the market. With our massive stock of flower, excellent for creating extracts and concentrates, we’re desirous to enter the patron extract market that can turn out to be an vital a part of our enterprise for years to come back. Due to our low-cost of manufacturing, we will likely be getting into the market with the flexibility to be very aggressive with anybody on the market. These are very busy and thrilling instances and I’m thrilled we are going to quickly have the ability to present what we will do on this section of the market.”
At the moment, SpeakEasy is licenced to promote its dried flower to customers. With the addition of its anticipated gross sales modification, the Firm will likely be nicely positioned to enter the market with a strong lineup of merchandise starting from easy artisan model concentrates to extra complicated stay resin vape carts. Formulations have been ready and types are able to launch upon receipt of the modification. The power to create a big and various vary of merchandise and have the ability to enter every market with a low worth level is predicted to present SpeakEasy a major benefit over firms with out an out of doors flower manufacturing space.
Maintaining manufacturing and processing in-house is a important solution to hold prices low. SpeakEasy, in partnership with Frontier Labs, produces, processes and packages its product with out shedding margin to different firms by contracting out or taking over the price of delivery between services. With SpeakEasy’s aim of competing instantly with “black market” pricing, maintaining prices as little as doable is essential to our success. Beginning with our low-cost enter materials, which is predicted to be among the many lowest within the {industry}, and carrying on to completed product by utilizing environment friendly, value efficient strategies accomplished in-house, SpeakEasy is ready to go these value financial savings on to customers and be a powerful competitor out there.
Founder, Marc Geen, states, “Having a worth benefit, specializing in real high-quality and branding that’s rooted within the legacy BC market will give us the chance to face out from the gang. We’re a singular firm for a lot of causes, and I imagine we will make ourselves well-known for all the proper causes throughout the nation.”
Ikanik Farms, Inc. (CSE: IKNK.U) announced that Pideka SAS., a wholly-owned subsidiary of Ikanik Farms, has efficiently accomplished its cooperative settlement with SGS Colombia SAS to design, provoke, develop, and implement a normative normal for the worldwide certification of medicinal hashish. This certification works to determine a brand new baseline normal for the standard and security of pharmaceutical grade hashish merchandise referred to as the “GPTCP”, or “Good Manufacturing Transformation & Commercialization Practices Hashish Pharma”.
“Finishing this collaborative certificates with SGS Colombia is a milestone achievement and a mirrored image of the corporate’s dedication to best-in-class high quality for the hashish {industry}.” stated Brian Baca, CEO of Ikanik Farms.
The GPTCP certificates ensures the corporate maintains worldwide requirements and differentiates itself by adhering to a world benchmark normal of high quality for the manufacturing hashish.
With the collaborative improvement of the SGS licensed seal of self-regulation and sustainability, {industry} greatest practices are promoted and fosters a aggressive strategy to high quality, by way of greatest at school and standardized processes throughout the {industry}, offering finish customers with product confidence.
The GPTCP encompasses sides of the necessities underneath varied requirements such because the BPA, BPM, INVIMA, ICA, ISO 9001, SG-SST, EUGMP at each the nationwide (Colombian) and worldwide ranges.
The standard certification and supply of high-caliber merchandise is among the Firm’s key aims, supported by way of working certifications obtained for its operations, together with (GACP, GMP FARMA, ISO-9001, and EUGMP)
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically built-in hashish chief with core operations in Latin America and Europe, announced that it has acquired UK Persevering with Skilled Growth (“CPD”) accreditation for Khiron Academy, the Firm’s world medical hashish schooling platform.
Moreover, following its accreditation, the Firm has entered right into a strategic partnership with Cellen Therapeutics, a frontrunner in digital healthcare within the UK and fellow founding member of Venture Twenty21, to extend affected person entry by way of medical hashish schooling initially. Khiron Academy will likely be made out there to prescribers within the UK which have registered with Cellen’s MedCanHub, an rising schooling portal. Cellen is market chief, widely known for additionally launching the UK’s first digital ache clinic, Leva.
Tejinder Virk, President of Khiron Europe, commented, “Over the past 12 months, Khiron has seen a direct correlation between doctor schooling and affected person entry. With Khiron Academy’s CPD accreditation and thru our strategic partnership with Cellen Therapeutics, we’re positioned to achieve a rising variety of medical professionals, and in flip, present sufferers with higher entry to medical hashish merchandise.”
Eric Bystrom, CEO of Cellen commented, “We’re happy to be becoming a member of forces with Khiron on educating prescribing specialists within the UK. Khiron is a transparent world chief in medical hashish schooling. We share widespread values in bettering affected person lives by educating docs and optimizing the usual of medical care. Our intention is to create a sensible information for responsibly prescribing sufferers with protected and efficacious medical hashish merchandise.”
Within the UK, Khiron continues to leverage academic supplies developed by the Firm to coach medical professionals in Latin America, together with medical knowledge from hundreds of Khiron sufferers. Along with Cellen’s MedCanHub (accessible to medical professionals at https://medcanhub.cellenhealth.com/ ), Khiron Academy is obtainable to members of the Medical Hashish Clinicians Society (MCCS) and core to the coaching of prescribing specialists for Venture Twenty21, a 20,000-patient observational research backed Drug Science in UK.
To this point, the Firm has educated almost 1000 medical professionals in Latin America and the UK. Over the past 12 months, physicians educated by Khiron in Latin America have issued over 13,000 prescriptions, with a compound month-to-month progress charge of almost 50%. Khiron Academy will likely be a platform for sharing the Firm’s medical experience, at the side of medical knowledge arising from Khiron’s wholly-owned clinics in LatAm.
Investor concepts reminds all listeners to learn our disclaimers and disclosures on the Investorideas.com web site and that this podcast is just not an endorsement to purchase services or products or securities. Traders are reminded all funding includes threat and doable lack of funding.
Be taught extra about our hashish podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Traders can commerce these shares and different concepts on our website utilizing our list of top stock trading apps together with Robinhood , Acorn, Stash and others.
To listen to extra Investorideas.com podcasts go to: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are additionally out there on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms out there.
Potcasts is now an authorized phrase mark Trademark on the blockchain by way of Cognate, Inc. CM Certification-Registration Quantity: 10468217708
About Investorideas.com – Information that Evokes Huge Investing Concepts
Investorideas.com is a acknowledged information supply publishing third occasion information, analysis and unique monetary content material. Find out about investing in shares and sector developments with our information alerts, articles, podcasts and movies, hashish, crypto, AI and IoT, mining, sports activities biotech, water, renewable vitality and extra. Investor Concept’s unique branded content material consists of the next podcasts and columns: Crypto Corner, Play by Play sports activities and inventory information column, Investor Ideas Potcasts Hashish Information and Shares on the Transfer podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital writer of third occasion sourced information, articles and fairness analysis in addition to creates unique content material, together with video, interviews and articles. Authentic content material created by investorideas is protected by copyright legal guidelines aside from syndication rights. Our website doesn’t make suggestions for purchases or sale of shares, providers or merchandise. Nothing on our websites must be construed as a proposal or solicitation to purchase or promote merchandise or securities. All investing includes threat and doable losses. This website is at present compensated for information publication and distribution, social media and advertising, content material creation and extra. Disclosure is posted for every compensated information launch, content material printed /created if required however in any other case the information was not compensated for and was printed for the only curiosity of our readers and followers.
Contact administration and IR of every firm instantly relating to particular questions.
Extra disclaimer information: https://www.investorideas.com/About/Disclaimer.asp Be taught extra about publishing your information launch and our different information providers on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
World traders should adhere to rules of every nation. Please learn Investorideas.com privateness coverage: https://www.investorideas.com/About/Private_Policy.asp
Investor Concepts doesn’t condone the usage of hashish besides the place permissible by regulation. Our website doesn’t possess, distribute, or promote hashish merchandise.
Observe us on Hashish Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/investorideas_potcast/
Obtain our Mobile App for iPhone and Android
Contact Investorideas.com
800-665-0411
